Table:
begin	end	state
1	28	cytoplasmic
29	48	transmembrane
49	53	non-cytoplasmic
54	72	transmembrane
73	102	cytoplasmic
103	124	transmembrane
125	142	non-cytoplasmic
143	161	transmembrane
162	171	cytoplasmic
172	191	transmembrane
192	210	non-cytoplasmic
211	234	transmembrane
235	254	cytoplasmic
255	277	transmembrane
278	300	non-cytoplasmic
301	323	transmembrane
324	344	cytoplasmic
345	362	transmembrane
363	366	non-cytoplasmic
367	391	transmembrane
392	403	cytoplasmic
404	424	transmembrane
425	426	non-cytoplasmic

Input:
>Pf1N1B4_4562 FitnessBrowser__pseudo1_N1B4:Pf1N1B4_4562
MNDQANSVDERYVAATPASLESWNRHDTTWMLGLFGTAIGAGTLFLPINAGLGGFWPLLI
LAVLAFPMTFYAHRGLTRFVLSGREGADITEVVEEHFGIKAGALITLLYFFAIFPILLIY
SVALTNTVGSFLEHQLHIMPPPRAVLSFVLILGLLAVVRCGEQVIVKAMSLMVYPFIVAL
LFLAVFLVPHWNGGILSTASTLPESSALLHTLWLAIPVMVFSFNHSPIISAFAVDQKRRY
GAHAEERSSQILSRAHLLMVVMVLFFVFSCVLTLSPAQLAEAKAQNLSILSYLANHFSNP
TIAFAAPLIAFVAISKSFLGHYIGASEGLKGLIIKSGKRPAPKTLDRMTAAFMLVVCWIV
ATLNPSILGMIETLGGPIIAAILFLMPMYAVRKVPAMARFRGQASNVFVTAVGLVAISAL
IYSLTA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server